Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Clinical

Say Cheese: Oral Health in Scleroderma and Sjögren's Disease

Wednesday, October 29, 2025
8:00 AM – 9:00 AM Central Time

    Moderator(s)

  • CP

    Cristina Padilla, MD, MS (she/her/hers)

    University of Pittsburgh
    Pittsburgh, Pennsylvania, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • DeAnna Baker Frost, MD, PhD

    Assistant Professor
    Medical University of South Carolina
    Charleston, South Carolina, United States

    Disclosure(s): Allogene: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing)

    • Session Coordinator(s)

  • DeAnna Baker Frost, MD, PhD

    Assistant Professor
    Medical University of South Carolina
    Charleston, South Carolina, United States

    Disclosure(s): Allogene: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing)

  • Elizabeth Volkmann, MD, MS

    Associate Professor, Division of Rheumatology
    University of California, Los Angeles
    Los Angeles, California, United States

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Atyr Pharma: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)

Oral health is impacted, which not only leads to disfigurement and nutritional concerns but also cause mental and psychological stress to patients. In this session, the goal is to discuss unique oral manifestations, which can occur in patients with scleroderma and Sjögren's disease. Presenters will provide a background of the basic science causing specific disease characteristics that impacts the mouth. Finally, there will be a discussion on potential collaborations between dental health providers and rheumatologists, targeted and symptomatic treatment options, and guidelines that are needed for patient education and improved oral health.

Learning Objectives:

  • Distinguish the unique manifestations of oral health challenges and their psychological effects on in patients with scleroderma
  • Assess the patient education and collaboration opportunities that exist between rheumatologists and dental medicine providers
  • Assess the current oral health therapeutic options and guidelines for patients with scleroderma

Presentations:

  • 8:00 AM – 8:30 AM Central Time
    Overview of Periodontal and Gingival Disease in Scleroderma and Sjögren's Disease

    Speaker: Andrew Leask, PhD – University of Saskatchewan

  • 8:30 AM – 9:00 AM Central Time
    Treatment Options for Oral Disease in Scleroderma and Sjögren's Disease

    Speaker: Natalia Trehan, DMD (she/her/hers) – Medical University of South Carolina